Ketamine Therapy in Seattle
Ketamine occupies a unique position in the landscape of psychedelic medicine. It is the only medicine on this page that is currently legal for therapeutic use in the United States. If you’ve been curious but felt uncertain about accessing it, ketamine may be the most accessible starting point.
Originally developed as an anesthetic, ketamine has been used off-label for depression for years. The FDA has since approved its close relative esketamine (Spravato) specifically for treatment-resistant depression, marking a significant moment in the mainstream recognition of psychedelic-adjacent medicine.
Ketamine for Depression
What makes ketamine for depression genuinely different from conventional antidepressants is speed. Most antidepressants require weeks to take effect. Multiple clinical trials from 2024 and 2025 have shown significant symptom reduction within hours of ketamine treatment, with sustained improvement in patients with treatment-resistant depression. When relief has felt out of reach for a long time, that kind of speed can bring real hope.
Multiple systematic reviews and randomized controlled trials confirm ketamine produces rapid antidepressant effects, including in patients who have tried multiple medications without relief. Ketamine-assisted psychotherapy builds on this foundation, borrowing from earlier psychedelic research to facilitate deep, rapid introspective work within a structured therapeutic framework.
Ketamine for PTSD, Anxiety and Addiction
Beyond depression, ketamine therapy is increasingly being explored for PTSD, anxiety, and alcohol use disorder, with promising early results across all three areas. While the research here is earlier-stage than the depression data, the clinical interest is significant and growing.
Ketamine and Postpartum Depression
Postpartum depression affects a significant number of new parents, and conventional antidepressants can often take weeks to reach therapeutic effect during a period when relief is urgently needed. Emerging research is pointing toward ketamine as a meaningful option for this population. A 2025 systematic review found that both ketamine and esketamine significantly decreased the incidence of postpartum depression compared to control groups, and a 2024 study found that a single low dose of esketamine given after childbirth reduced the risk of postpartum major depressive episodes by 75% in mothers with prenatal depression. Research also suggests that ketamine transmission in breastmilk is minimal, potentially offering an alternative for parents who are breastfeeding and concerned about continuous antidepressant exposure. As always, medical decisions around the postpartum period should be made in close consultation with a physician, OBGYN, or midwife.
What Ketamine Actually Feels Like
Unlike MDMA or psilocybin, ketamine produces a dissociative experience, a temporary sense of distance from ordinary reality that many people describe as deeply clarifying, even otherworldly. It is typically shorter than classic psychedelic experiences, lasting between 45 minutes and two hours depending on the form and dose. For many people it opens something unexpected: a loosening of rigid thought patterns, a softened relationship to pain, a glimpse of something beyond the story they’ve been living inside.
Beyond the Medicine
Ketamine is the only FDA-approved psychedelic-adjacent medicine currently available in Washington State, making it the most widely accessible option for people seeking this kind of healing. Clinical settings offer something real and valuable, and for many people, the medicine alone opens doors that nothing else could. What the research is increasingly reflecting is what many practitioners have long observed: preparation and integration deepen what becomes possible. They are often where the medicine’s gifts take root.
If you’ve had a ketamine experience and sensed that something important was left unprocessed, or if you are preparing for one and want to arrive genuinely ready, ketamine preparation and integration support may be a meaningful next step.
The information on this page reflects current research in psychedelic medicine and is offered purely for educational purposes, not as medical or psychiatric advice. I am not a licensed therapist or healthcare provider, and nothing here should replace professional medical care.
If you’re curious about what preparation, journey support, or integration might look like for you, I’d love to hear from you.